Neoparin, Inc.

Neoparin is committed to provide highest quality products and service for your present needs. We also recognize that the development of new products is necessary for continued success. We devote a large portion of our efforts to continuing development of innovative heparinoids. We welcome any suggestions, and will always strive to your needs.

Contact Details: 875A Island Drive, #266 Alameda California 94502 United States of America Tel: (510) 522-2813 Fax: (510) 522-0643 Email: neoparin@heparinoids.com WWW: www.heparinoids.com/

Loading...

BioNews Results for Neoparin, Inc.:
DATATRAK Announces Next Release of eClinical Product Suite	Applied Clinical Trials:  Oct 5 2008 7:53AM Matching: inc
Anika Therapeutics Announces Exclusive Canadian Distribution Agreement for ELEVESS(R) with Canderm Pharma Inc	SmartBrief:  Oct 5 2008 5:39AM Matching: inc
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners	KRON4:  Oct 4 2008 6:17AM Matching: inc
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners	KSLA:  Oct 4 2008 12:09AM Matching: inc
Connecticut Technology Council Announces UHY LLP Tech Top 40 Winners	KOTA Territory News:  Oct 4 2008 4:43AM Matching: inc
Promote your company here: BioNewsCast - Press Release Distribution	→View more Neoparin, Inc. news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 275 times since April 2007, the link to the organisation's website has been followed 59 times

Recent Search Terms used to find this page: neoparin | 510-522-0643 | Neoparin | Neoparin | f | f | t | neoparin | neoparin | neoparin | .

Search for more companies in Alameda

Search for more companies in California

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Neoparin, Inc.